Rs 154 crore plan formulated to implement strategies to reduce IMR by 2020

Published On 2019-06-02 04:00 GMT   |   Update On 2019-06-02 04:00 GMT

The action plan enlists the community and health facility-based interventions for accelerating rate of decline, which includes birth preparedness, home-based newborn care, mothers absolute affection (MAA), Intensified Diarrhoea Control Fortnight (IDCF), Universal Immunisation Programme (UIP), VHNDs and IMNCI.Srinagar:  The Jammu and Kashmir Government has formulated a comprehensive action...

Login or Register to read the full article

The action plan enlists the community and health facility-based interventions for accelerating rate of decline, which includes birth preparedness, home-based newborn care, mothers absolute affection (MAA), Intensified Diarrhoea Control Fortnight (IDCF), Universal Immunisation Programme (UIP), VHNDs and IMNCI.


Srinagar:  The Jammu and Kashmir Government has formulated a comprehensive action plan to reduce the Infant Mortality Rate (IMR) to a single digit by the year 2020 in line with the Sustainable Development Goals, an official spokesman said on Thursday.


He said the Health and Medical Education Department prepared the action plan with technical support from Norway-India Partnership Initiative (NIPI) teams, for which a Technical Expert Committee has been constituted, which had the members from Paediatrics and Obstetrics and Gynaecology departments of GMC Srinagar and Jammu.


Read Also:J&K: Newborn dies at Government Hospital, family alleges negligence


The action plan enlists the community and health facility-based interventions for accelerating rate of decline, which includes birth preparedness, home-based newborn care, mothers absolute affection (MAA), Intensified Diarrhoea Control Fortnight (IDCF), Universal Immunisation Programme (UIP), VHNDs and IMNCI.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News